alexa Viral Suppression in the Setting of Multidrug Resistance to Nelfinavir, Tenofovir and Abacavir: A Case Report | OMICS International | Abstract
ISSN 2155-6113

Journal of AIDS & Clinical Research
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Viral Suppression in the Setting of Multidrug Resistance to Nelfinavir, Tenofovir and Abacavir: A Case Report

Amy M Cheng1*, Rustin D Crutchley2, Meghann L Davis3, Carl Mayberry4 and Joseph C Gathe Jr.4

1Department of Pharmacy Practice Temple University School of Pharmacy, Philadelphia, PA, USA

2Department of Pharmacy Practice and Translational Research, University of Houston, College of Pharmacy, Houston, TX, USA

3Department of Pharmacy, Houston Methodist Hospital, Houston, TX, USA

4Therapeutic Concepts, P.A., Houston, TX, USA

*Corresponding Author:
Amy Cheng
Department of Pharmacy Practice Temple University School of Pharmacy
Philadelphia, PA, 3307 N. Broad Street Philadelphia
PA 19140, USA
Tel: 1 (215) 707-6980
Fax: 1 (215) 707-8326
E-mail: [email protected]

Received date: March 30, 2017; Accepted date: April 05, 2017; Published date: April 12, 2017

Citation: Cheng AM, Crutchley RD, Davis ML, Mayberry C, Gathe Jr JC (2017) Viral Suppression in the Setting of Multidrug Resistance to Nelfinavir, Tenofovir and Abacavir: A Case Report. J AIDS Clin Res 8:683. doi:10.4172/2155-6113.1000683

Copyright: © 2017 Cheng AM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

One major barrier to achieving the primary goals of antiretroviral therapy is the development of drug resistance mutations to antiretroviral agents which render them less effective. For patients who are treatment experienced with many drug resistance mutations, selection of an effective antiretroviral regimen becomes challenging. We report a case of a 55 year old male on tenofovir, abacavir and nelfinavir with multiple resistance mutations to each of these agents, yet able to maintain viral suppression and high CD4 T cell counts. This patient was subsequently switched to protease inhibitor monotherapy for the management of HIV in the setting of multidrug resistance.

Keywords

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7